• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西严重哮喘患者嗜酸性表型的流行情况:BRAEOS 研究。

Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study.

机构信息

. Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.

. Consultoria Médica e Pesquisa Clínica - CMPC - Sorocaba (SP) Brasil.

出版信息

J Bras Pneumol. 2022 Jul 8;48(3):e20210367. doi: 10.36416/1806-3756/e20210367. eCollection 2022.

DOI:10.36416/1806-3756/e20210367
PMID:35830052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9262440/
Abstract

OBJECTIVE

To assess the prevalence of the eosinophilic and allergic phenotypes of severe asthma in Brazil, as well as to investigate the clinical characteristics of severe asthma patients in the country.

METHODS

This was a cross-sectional study of adult patients diagnosed with severe asthma and managed at specialized centers in Brazil. The study was conducted in 2019.

RESULTS

A total of 385 patients were included in the study. Of those, 154 had a blood eosinophil count > 300 cells/mm3 and 231 had a blood eosinophil count of ≤ 300 cells/mm3. The median age was 54.0 years, and most of the patients were female, with a BMI of 29.0 kg/m2 and a history of allergy (81.6%). The prevalence of patients with a blood eosinophil count > 300 cells/mm3 was 40.0% (95% CI: 35.1-44.9), and that of those with a blood eosinophil count > 300 cells/mm3 and a history of allergy was 31.9% (95% CI: 27.3-36.6). Age and BMI showed positive associations with a blood eosinophil count > 300 cells/mm3 (OR = 0.97, p < 0.0001; and OR = 0.96, p = 0.0233, respectively), whereas the time elapsed since the onset of asthma symptoms showed an increased association with a blood eosinophil count > 300 cells/mm3 (OR = 1.02, p = 0.0011).

CONCLUSIONS

This study allowed us to characterize the population of severe asthma patients in Brazil, showing the prevalence of the eosinophilic phenotype (in 40% of the sample). Our results reveal the relevance of the eosinophilic phenotype of severe asthma at a national level, contributing to increased effectiveness in managing the disease and implementing public health strategies.

摘要

目的

评估巴西严重哮喘嗜酸性粒细胞和过敏表型的流行情况,并研究该国严重哮喘患者的临床特征。

方法

这是一项巴西专门中心管理的成人严重哮喘患者的横断面研究。该研究于 2019 年进行。

结果

共有 385 名患者纳入研究。其中,154 名患者血液嗜酸性粒细胞计数>300 细胞/mm3,231 名患者血液嗜酸性粒细胞计数≤300 细胞/mm3。中位年龄为 54.0 岁,大多数患者为女性,BMI 为 29.0kg/m2,有过敏史(81.6%)。血液嗜酸性粒细胞计数>300 细胞/mm3 的患者患病率为 40.0%(95%CI:35.1-44.9),血液嗜酸性粒细胞计数>300 细胞/mm3 且有过敏史的患者患病率为 31.9%(95%CI:27.3-36.6)。年龄和 BMI 与血液嗜酸性粒细胞计数>300 细胞/mm3 呈正相关(OR=0.97,p<0.0001;和 OR=0.96,p=0.0233),而哮喘症状发作后时间与血液嗜酸性粒细胞计数>300 细胞/mm3 呈正相关(OR=1.02,p=0.0011)。

结论

本研究对巴西严重哮喘患者人群进行了特征描述,显示了嗜酸性粒细胞表型的流行率(在样本的 40%中)。我们的结果揭示了国家层面严重哮喘嗜酸性粒细胞表型的重要性,有助于提高疾病管理的效果,并实施公共卫生策略。

相似文献

1
Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study.巴西严重哮喘患者嗜酸性表型的流行情况:BRAEOS 研究。
J Bras Pneumol. 2022 Jul 8;48(3):e20210367. doi: 10.36416/1806-3756/e20210367. eCollection 2022.
2
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.嗜酸粒细胞性和非嗜酸粒细胞性哮喘:全球真实严重哮喘队列中表型特征的专家共识框架。
Chest. 2021 Sep;160(3):814-830. doi: 10.1016/j.chest.2021.04.013. Epub 2021 Apr 19.
3
Full blood count parameters for the detection of asthma inflammatory phenotypes.用于检测哮喘炎症表型的全血细胞计数参数。
Clin Exp Allergy. 2014 Sep;44(9):1137-45. doi: 10.1111/cea.12345.
4
Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.根据血嗜酸性粒细胞标准,嗜酸性粒细胞性哮喘与贫困城市巴西人的疾病严重程度和控制不佳有关。
Respir Med. 2018 Dec;145:95-100. doi: 10.1016/j.rmed.2018.10.025. Epub 2018 Oct 23.
5
Asthma control and sputum eosinophils in adult patients: a cross-sectional study in southern Brazil.成人哮喘控制与痰嗜酸性粒细胞:巴西南部的一项横断面研究。
Sci Rep. 2023 Dec 5;13(1):21464. doi: 10.1038/s41598-023-48381-1.
6
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities.基层医疗中的哮喘表型分析:在所有哮喘严重程度中应用国际重症哮喘注册嗜酸粒细胞表型算法
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4353-4370. doi: 10.1016/j.jaip.2021.07.056. Epub 2021 Aug 14.
7
PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study.黎巴嫩重度哮喘患者中嗜酸性粒细胞表型的患病率:PREPARE研究结果
Allergy Asthma Clin Immunol. 2023 Sep 8;19(1):80. doi: 10.1186/s13223-023-00815-1.
8
Moderate accuracy of peripheral eosinophil count for predicting eosinophilic phenotype in steroid-naïve non-atopic adult asthmatics.外周血嗜酸性粒细胞计数对预测未使用过类固醇的非特应性成年哮喘患者的嗜酸性粒细胞表型具有中等准确性。
Intern Med. 2012;51(7):717-22. doi: 10.2169/internalmedicine.51.6834. Epub 2012 Apr 1.
9
Refractory asthma phenotyping based on immunoglobulin E levels and eosinophilic counts: A real life study.基于免疫球蛋白 E 水平和嗜酸性粒细胞计数的难治性哮喘表型分析:一项真实世界研究。
Respir Med. 2019 Oct-Nov;158:55-58. doi: 10.1016/j.rmed.2019.10.003. Epub 2019 Oct 6.
10
Serum eosinophil peroxidase (EPO) levels in asthmatic patients.哮喘患者的血清嗜酸性粒细胞过氧化物酶(EPO)水平。
Allergy. 1997 Apr;52(4):417-22. doi: 10.1111/j.1398-9995.1997.tb01021.x.

引用本文的文献

1
Baseline characteristics of patients from the Brazilian Severe Asthma Registry: the REBRAG study.巴西重症哮喘登记处患者的基线特征:REBRAG研究。
J Bras Pneumol. 2025 Sep 8;51(3):e20240427. doi: 10.36416/1806-3756/e20240427. eCollection 2025.
2
Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST).真实世界中美泊利珠单抗治疗重度哮喘的疗效:多国、自身对照、努卡莱斯有效性研究(NEST)的结果。
Adv Ther. 2024 Nov;41(11):4008-4031. doi: 10.1007/s12325-024-02967-x. Epub 2024 Aug 31.
3
Asthma control and sputum eosinophils in adult patients: a cross-sectional study in southern Brazil.成人哮喘控制与痰嗜酸性粒细胞:巴西南部的一项横断面研究。
Sci Rep. 2023 Dec 5;13(1):21464. doi: 10.1038/s41598-023-48381-1.
4
[The profile of severe asthmatics: Results from a specialized asthma clinic].[重度哮喘患者概况:一家专业哮喘诊所的研究结果]
Tuberk Toraks. 2023 Jun;71(2):156-165. doi: 10.5578/tt.20239919.
5
Severe asthma phenotyping: does the definition of different phenotypes matter?重度哮喘的表型分析:不同表型的定义重要吗?
J Bras Pneumol. 2022 Jul 8;48(3):e20220176. doi: 10.36416/1806-3756/e20220176.

本文引用的文献

1
Biologic Therapies for Severe Asthma.重度哮喘的生物疗法
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
2
Severe asthma in Brazil: from diagnosis to treatment.巴西的重度哮喘:从诊断到治疗
J Bras Pneumol. 2021 Dec 15;47(6):e20210386. doi: 10.36416/1806-3756/e20210386.
3
2021 Brazilian Thoracic Association recommendations for the management of severe asthma.2021 年巴西胸科协会严重哮喘管理建议。
J Bras Pneumol. 2021 Dec 15;47(6):e20210273. doi: 10.36416/1806-3756/e20210273. eCollection 2021.
4
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘和糖皮质激素依赖患者的疗效:来自法国早期准入项目的结果。
Eur Respir J. 2020 Jun 25;55(6). doi: 10.1183/13993003.02345-2019. Print 2020 Jun.
5
2020 Brazilian Thoracic Association recommendations for the management of asthma.2020 年巴西胸科协会哮喘管理建议。
J Bras Pneumol. 2020 Mar 2;46(1):e20190307. doi: 10.1590/1806-3713/e20190307. eCollection 2020.
6
Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status.对比不同地理位置、种族和社会经济地位的巴西 ProAR 和欧洲 U-BIOPRED 成人队列中哮喘的相似性。
Respir Med. 2020 Jan;161:105817. doi: 10.1016/j.rmed.2019.105817. Epub 2019 Nov 26.
7
Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.按年龄和哮喘发病年龄划分的可接受美泊利珠单抗治疗的重度哮喘患者比例。
J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2689-2696.e2. doi: 10.1016/j.jaip.2019.05.053. Epub 2019 Jun 13.
8
The characterization of asthma with blood eosinophilia in adults in Latin America.拉丁美洲成年人中伴有血液嗜酸性粒细胞增多的哮喘特征
J Asthma. 2019 Nov;56(11):1138-1146. doi: 10.1080/02770903.2018.1520863. Epub 2018 Nov 5.
9
Type 2 immunity in asthma.哮喘中的2型免疫
World Allergy Organ J. 2018 Jun 26;11(1):13. doi: 10.1186/s40413-018-0192-5. eCollection 2018.
10
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.严重哮喘研究计划(SARP III)队列的基线特征:年龄差异。
J Allergy Clin Immunol Pract. 2018 Mar-Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.